<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism - Bhutia, S - 2013 | Cochrane Library</title> <meta content="Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism - Bhutia, S - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003074.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism - Bhutia, S - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003074.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003074.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism" name="citation_title"/> <meta content="Sherab Bhutia" name="citation_author"/> <meta content="The Townsville Hospital" name="citation_author_institution"/> <meta content="sbhutia@hotmail.co.uk" name="citation_author_email"/> <meta content="Peng F Wong" name="citation_author"/> <meta content="James Cook University Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD003074.pub3" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/07/16" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003074.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003074.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003074.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [*administration &amp; dosage, adverse effects]; Drug Administration Schedule; Hemorrhage [chemically induced]; Heparin, Low‐Molecular‐Weight [*administration &amp; dosage, adverse effects]; Pulmonary Embolism [drug therapy]; Randomized Controlled Trials as Topic; Recurrence; Thromboembolism [*drug therapy]; Venous Thrombosis [*drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003074.pub3&amp;doi=10.1002/14651858.CD003074.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="z6k50IFd";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003074\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003074\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003074.pub3",title:"Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism",firstPublishedDate:"Jul 16, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=z6k50IFd&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003074.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003074.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003074.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003074.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003074.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003074.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003074.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003074.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003074.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003074.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2383 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003074.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#CD003074-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#CD003074-sec-0064"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#CD003074-sec-0029"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#CD003074-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#CD003074-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#CD003074-sec-0051"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/full#CD003074-sec-0063"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/appendices#CD003074-sec-0069"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/table_n/CD003074StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/table_n/CD003074StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information#CD003074-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Sherab Bhutia</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information#CD003074-cr-0003">Peng F Wong</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information/en#CD003074-sec-0085">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 16 July 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003074.pub3">https://doi.org/10.1002/14651858.CD003074.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003074-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003074-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003074-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003074-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003074-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD003074-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003074-abs-0001" lang="en"> <section id="CD003074-sec-0001"> <h3 class="title" id="CD003074-sec-0001">Background</h3> <p>In the initial treatment of venous thromboembolism (VTE) low molecular weight heparin (LMWH) is administered once or twice daily. A once daily treatment regimen is more convenient for the patient and may optimise home treatment. However, it is not clear whether a once daily treatment regimen is as safe and effective as a twice daily treatment regimen. This is the second update of a review first published in 2003. </p> </section> <section id="CD003074-sec-0002"> <h3 class="title" id="CD003074-sec-0002">Objectives</h3> <p>To compare the efficacy and safety of once daily versus twice daily administration of LMWH. </p> </section> <section id="CD003074-sec-0003"> <h3 class="title" id="CD003074-sec-0003">Search methods</h3> <p>For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co‐ordinator searched the Specialised Register (last searched May 2013) and CENTRAL (2013, Issue 4). </p> </section> <section id="CD003074-sec-0004"> <h3 class="title" id="CD003074-sec-0004">Selection criteria</h3> <p>Randomised clinical trials in which LMWH given once daily is compared with LMWH given twice daily for the initial treatment of VTE. </p> </section> <section id="CD003074-sec-0005"> <h3 class="title" id="CD003074-sec-0005">Data collection and analysis</h3> <p>Two review authors assessed trials for inclusion and extracted data independently.</p> </section> <section id="CD003074-sec-0006"> <h3 class="title" id="CD003074-sec-0006">Main results</h3> <p>Five studies were included with a total of 1508 participants. The pooled data showed no statistically significant difference in recurrent VTE between the two treatment regimens (OR 0.82, 0.49 to 1.39; P = 0.47). A comparison of major haemorrhagic events (OR 0.77, 0.40 to 1.45; P = 0.41), improvement of thrombus size (OR 1.41, 0.66 to 3.01; P = 0.38) and mortality (OR 1.14, 0.62 to 2.08; P = 0.68) also showed no statistically significant differences between the two treatment regimens. None of the five included studies reported data on post‐thrombotic syndrome. </p> </section> <section id="CD003074-sec-0007"> <h3 class="title" id="CD003074-sec-0007">Authors' conclusions</h3> <p>Once daily treatment with LMWH is as effective and safe as twice daily treatment with LMWH. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003074-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003074-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003074-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003074-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003074-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD003074-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003074-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003074-abs-0004" lang="en"> <h3>Once versus twice daily injections of low molecular weight heparin for the initial treatment of blood clots in the veins </h3> <p>Blood clots in the veins (venous thromboembolism (VTE)) can develop spontaneously or after surgery or bed rest. Venous thromboembolism can be life threatening if clots travel to the lungs. Blood‐thinning drugs such as heparin are used to dissolve clots. Low molecular weight heparin (LMWH) can be given by injection, enabling people to leave hospital. The usual treatment is two injections a day, but once a day would be more convenient. This review included five studies with a combined total of 1508 participants. The combined data showed no statistically significant difference in recurrent VTE between the once daily and twice daily treatment regimens. A comparison of major bleeding events, improvement of the blood clot size and death also showed no statistically significant difference between the two treatment regimens. None of the five included studies reported information on post‐thrombotic syndrome (ongoing swelling of the affected leg, pain, and skin changes). One daily injection with LMWH is therefore as effective and safe as twice daily injections. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003074-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003074-sec-0064"></div> <h3 class="title" id="CD003074-sec-0065">Implications for practice</h3> <section id="CD003074-sec-0065"> <p>This review has shown that once daily administration of LMWH for the initial treatment of venous thromboembolism is as safe and effective as a twice daily regimen. Either regimen is therefore acceptable in clinical practice. </p> </section> <h3 class="title" id="CD003074-sec-0066">Implications for research</h3> <section id="CD003074-sec-0066"> <p>Further research should be performed to investigate whether the safety and efficacy of different LMWH compounds are comparable in a once or twice daily regimen. These studies should also focus on the impact of different LMWH regimens in people with PE. A large randomised trial of at least two years' duration should be performed to determine the effects of dosing frequency on long‐term sequelae of venous thromboembolism, such as the development of the post‐thrombotic syndrome. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003074-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003074-sec-0029"></div> <section id="CD003074-sec-0030"> <h3 class="title" id="CD003074-sec-0030">Description of the condition</h3> <p>Venous thromboembolism (VTE) is a common disease with an annual incidence of between two and three cases per 1000 inhabitants (<a href="./references#CD003074-bbs2-0047" title="AndersonFAJr , WheelerHB , GoldbergRJ , HosmerDW , PatwardhanNA , JovanovicB , et al. A population‐based perspective of the hospital incidence and case‐fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Archives of Internal Medicine1991;151(5):933‐8. ">Anderson 1991</a>; <a href="./references#CD003074-bbs2-0063" title="NordstromM , LindbladB , BergqvistD , KjellstromT . A prospective study of the incidence of deep‐vein thrombosis within a defined urban population. Journal of Internal Medicine1992;232(2):155‐60. ">Nordstrom 1992</a>). Risk factors for VTE can be acquired through trauma, surgery or periods of immobilisation (<a href="./references#CD003074-bbs2-0056" title="HeitJA , SilversteinMD , MohrDN , PettersonTM , O'FallonWM , MeltonLJ3rd . Risk factors for deep vein thrombosis and pulmonary embolism: a population‐based case‐control study. Archives of Internal Medicine2000;160(6):809‐15. ">Heit 2000</a>) or can be inherited, e.g. Factor V Leiden mutation or protein C deficiency (<a href="./references#CD003074-bbs2-0048" title="BertinaRM , KoelemanBP , KosterT , RosendaalFR , DirvenRJ , DeRondeH , et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature1994;369(6475):64‐7. ">Bertina 1994</a>; <a href="./references#CD003074-bbs2-0055" title="HeijboerH , BrandjesDPM , BüllerHR , SturkA , TenCateJW . Deficiencies of coagulation‐inhibiting and fibrinolytic proteins in outpatients with deep‐vein thrombosis. New England Journal of Medicine1990;323(22):1512‐6. ">Heijboer 1990</a>). The disease requires immediate anticoagulant therapy, as left untreated, VTE has a high morbidity and can be fatal. </p> </section> <section id="CD003074-sec-0031"> <h3 class="title" id="CD003074-sec-0031">Description of the intervention</h3> <p>Intravenous administration of unfractionated heparin (UFH) for approximately one week has been the standard initial treatment for VTE for decades (<a href="./references#CD003074-bbs2-0057" title="HirshJ . Drug therapy: Heparin. New England Journal of Medicine1991;324(22):1565‐74. ">Hirsh 1991</a>). A group of anticoagulants derived from the unfractionated form of heparin has become available, namely low molecular weight heparins (LMWHs). Low molecular weight heparins have pharmacokinetic advantages over UFH, including a longer half‐life (the compounds remain active within the body for longer), and a more predictable anticoagulant response (the dose does not have to be adjusted continually to maintain the desired level of coagulability) (<a href="./references#CD003074-bbs2-0058" title="HirshJ , LevineMN . Low molecular weight heparin. Blood1992;79(1):1‐17. ">Hirsh 1992</a>). Hence, a fixed, body‐weight‐adjusted dose of LMWH can be administered subcutaneously without the need for laboratory monitoring. This facilitates the initial treatment and leads to a shorter hospitalisation period for people with VTE, as treatment can take place partially or entirely at home (<a href="./references#CD003074-bbs2-0053" title="ErkensPMG , PrinsMH . Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD001100.pub3] ">Erkens 2010</a>; <a href="./references#CD003074-bbs2-0061" title="KoopmanMM , PrandoniP , PiovellaF , OckelfordPA , BrandjesDP , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low‐molecular‐weight heparin administered at home. The Tasman Study Group. New England Journal of Medicine1996;334(11):682‐7. ">Koopman 1996</a>). </p> </section> <section id="CD003074-sec-0032"> <h3 class="title" id="CD003074-sec-0032">How the intervention might work</h3> <p>In the trials that established the efficacy of LMWH for the initial treatment of VTE, LMWH was usually given twice a day (<a href="./references#CD003074-bbs2-0015" title="BrattG , AbergW , JohanssonM , TörnebohmE , GranqvistS , LocknerD . Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT). Thrombosis and Haemostasis1990;64(4):506‐10. ">Bratt 1990</a>; <a href="./references#CD003074-bbs2-0024" title="HarenbergJ , StehleG , BlauthM , HuckK , MallK , HeeneDL . Dosage, anticoagulant, and antithrombotic effects of heparin and low‐molecular‐weight heparin in the treatment of deep vein thrombosis. Seminars in Thrombosis and Hemostasis1997;23(1):83‐90. ">Harenberg 1997</a>; <a href="./references#CD003074-bbs2-0064" title="PrandoniP , LensingAWA , BüllerHR , CartaM , CogoA , VigoM , et al. Comparison of subcutaneous low‐molecular‐weight heparin with intravenous standard heparin in proximal deep‐vein thrombosis. Lancet1992;339(8791):441‐5. ">Prandoni 1992</a>) but there are also trials in which LMWH was administered once a day (<a href="./references#CD003074-bbs2-0022" title="FiessingerJN , Lopez‐FernandezM , GattererE , GranqvistS , KherA , OlssonCG , et al. Once‐daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis. Thrombosis and Haemostasis1996;76(2):195‐9. ">Fiessinger 1996</a>; <a href="./references#CD003074-bbs2-0032" title="LindmarkerP , HolmströmM , GranqvistS , JohnssonH , LocknerD . Comparison of once‐daily subcutaneous Fragmin(TM) with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thrombosis and Haemostasis1994;72(2):186‐90. ">Lindmarker 1994</a>). In the past few years, head to head comparisons of once versus twice daily LMWH regimens have been performed (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>; <a href="./references#CD003074-bbs2-0004" title="PartschH , KechavarzB , MostbeckA , KöhnH , LippC . Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once‐ or twice‐daily low‐molecular‐weight heparin. Journal of Vascular Surgery1996;24(5):774‐82. ">Partsch 1996</a>). </p> </section> <section id="CD003074-sec-0033"> <h3 class="title" id="CD003074-sec-0033">Why it is important to do this review</h3> <p>A single daily injection of LMWH is more convenient for people and may optimise home treatment. In addition, the appeal on economic resources is lower in a once daily administration regimen. However, it is conceivable that twice daily LMWH results in a more stable level of anticoagulation and thus in fewer complications. </p> <p>This review evaluates the relative efficacy and safety of LMWH administered once daily versus twice daily. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003074-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003074-sec-0034"></div> <p>To assess the relative efficacy (in terms of recurrent venous thromboembolism) and safety (i.e. major haemorrhagic events) of once daily low molecular weight heparin (LMWH) versus twice daily LMWH administration in the initial treatment of people with venous thromboembolism. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003074-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003074-sec-0035"></div> <section id="CD003074-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003074-sec-0037"> <h4 class="title">Types of studies</h4> <p>Only randomised trials with an intention‐to‐treat analysis were included. Quasi‐randomised trials were not included. Studies were excluded if they were duplicate reports; or preliminary reports of data later presented in full; and if they were dose‐finding studies, in which the efficacy and safety can be under‐ or overestimated; or if the difference in initial treatment was confounded by differences in concomitant medication or long‐term medication. </p> </section> <section id="CD003074-sec-0038"> <h4 class="title">Types of participants</h4> <p>People with VTE, i.e. deep vein thrombosis (DVT) or pulmonary embolism (PE) or both, confirmed by objective tests were included. The following criteria were accepted for the diagnosis of VTE: </p> <p> <ul id="CD003074-list-0001"> <li> <p>the suspected DVT was confirmed by either venography or compression ultrasound if venography was not feasible; </p> </li> <li> <p>the suspected PE was confirmed by pulmonary angiography or a high probability ventilation/perfusion lung scan; </p> </li> <li> <p>an associated DVT was proven by either venography or compression ultrasound.</p> </li> </ul> </p> </section> <section id="CD003074-sec-0039"> <h4 class="title">Types of interventions</h4> <p>Once versus twice daily administration of a fixed dose of subcutaneous LMWH as the initial treatment for VTE. Brands, doses and duration of treatment medication were registered but were not criteria for excluding trials. </p> </section> <section id="CD003074-sec-0040"> <h4 class="title">Types of outcome measures</h4> <section id="CD003074-sec-0041"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome measures were:</p> <p> <ul id="CD003074-list-0002"> <li> <p>symptomatic recurrent VTE, i.e. DVT or PE, or both during the initial treatment and during follow up; </p> </li> <li> <p>major haemorrhagic episodes during initial treatment or within 48 hours after treatment cessation. </p> </li> </ul> </p> <p>A diagnosis of recurrent deep venous thrombosis was accepted if one of the following criteria was met: </p> <p> <ul id="CD003074-list-0003"> <li> <p>a new constant intraluminal filling defect was found which was not present on the last available venogram, or extension of the thrombus on ultrasound, </p> </li> <li> <p>if the venogram was not diagnostic: either an abnormal 125I‐fibrinogen leg scan or abnormal impedance plethysmogram or ultrasound result that had been normal before the suspected recurrent episode (<a href="./references#CD003074-bbs2-0050" title="BüllerHR , LensingAWA , HirschJ , tenCateJW . Deep vein thrombosis: new non‐invasive diagnostic tests. Thrombosis and Haemostasis1991;66(1):133‐7. ">Büller 1991</a>). </p> </li> </ul> </p> <p>A diagnosis of pulmonary embolism was accepted if one of the following criteria was met: </p> <p> <ul id="CD003074-list-0004"> <li> <p>a segmental defect was found on the perfusion lung scan unmatched on the previous ventilation scan or chest roentgenogram; </p> </li> <li> <p>a positive pulmonary angiography or spiral computed tomography (CT);</p> </li> <li> <p>pulmonary embolism at autopsy.</p> </li> </ul> </p> <p>Haemorrhagic events were considered to be major if they were intracranial, retroperitoneal, led directly to death, necessitated transfusion, warranted interruption of antithrombotic treatment or required operation. All other bleeding events were classified as minor. </p> </section> <section id="CD003074-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p>The main secondary outcome was extension of the thrombus size. In addition, where data on overall mortality and incidence of the post‐thrombotic syndrome were presented, these data were evaluated as well. </p> </section> </section> </section> <section id="CD003074-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <p>There were no language restrictions.</p> <section id="CD003074-sec-0044"> <h4 class="title">Electronic searches</h4> <p>For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co‐ordinator (TSC) searched the Specialised Register (last searched May 2013) and the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 4, part of <i>The Cochrane Library</i>, (<a href="http://www.thecochranelibrary.com" target="_blank">www.thecochranelibrary.com</a>). See (<a href="./appendices#CD003074-sec-0070">Appendix 1</a>) for details of the search strategy used to search CENTRAL. The Specialised Register is maintained by the TSC and is constructed from weekly electronic searches of MEDLINE, EMBASE, CINAHL, AMED, and through handsearching relevant journals. The full list of the databases, journals and conference proceedings which have been searched, as well as the search strategies used are described in the (<a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a>) section of the Cochrane Peripheral Vascular Diseases Group module in <i>The Cochrane Library</i> (<a href="http://www.thecochranelibrary.com" target="_blank">www.thecochranelibrary.com</a>). </p> </section> <section id="CD003074-sec-0045"> <h4 class="title">Searching other resources</h4> <p>The reference lists of articles retrieved by electronic searches were searched for additional citations. </p> </section> </section> <section id="CD003074-sec-0046"> <h3 class="title" id="CD003074-sec-0046">Data collection and analysis</h3> <section id="CD003074-sec-0047"> <h4 class="title">Selection of trials</h4> <p>Two review authors (for the original review MM, CVD and for the update SB, PW) independently evaluated the eligibility and methodological quality of the trials. Disagreements were resolved through discussion and consensus. </p> </section> <section id="CD003074-sec-0048"> <h4 class="title">Quality of trials</h4> <p>Studies were evaluated to extract information on study details including route of administration, intensity of heparin therapy, and intensity of oral anticoagulant therapy. The adequacy of concealment of allocation prior to randomisation and blinding of the outcome measurement was assessed, based indirectly on the criteria of Jadad (<a href="./references#CD003074-bbs2-0060" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. ">Jadad 1996</a>). Trials without adequate concealment of allocation and/or without blinded outcome measurement were excluded. <br/> <br/> For future updates of the review, where the information in the original article is not clear, we will contact the authors for clarification. To date this has not been necessary. </p> </section> <section id="CD003074-sec-0049"> <h4 class="title">Data extraction</h4> <p>For the original review, two review authors (MM, CVD) extracted data independently. The following information was collected: patient characteristics (age, gender, co‐morbidity); incidence of recurrent VTE; incidence of haemorrhagic events; incidence of thrombus size improvement; and, additionally, mortality and the incidence of a post‐thrombotic syndrome. Disagreements were resolved according to the same procedure used for the selection of trials. No authors were contacted for additional information. </p> </section> <section id="CD003074-sec-0050"> <h4 class="title">Statistical analysis</h4> <p>The following comparisons were made between once and twice daily LMWH:</p> <p> <ul id="CD003074-list-0005"> <li> <p>incidence of symptomatic recurrent DVT and PE during the initial treatment and during follow up; </p> </li> <li> <p>number of people in each group with improved venographic score;</p> </li> <li> <p>frequency of major haemorrhagic episodes during initial treatment;</p> </li> <li> <p>overall mortality at the end of follow up;</p> </li> <li> <p>incidence of people suffering from a post‐thrombotic syndrome at the end of follow up. </p> </li> </ul> </p> <p>An odds ratio (OR) for all outcome measurements within each study was calculated (an OR of less than one favours once daily). Subsequently, a chi‐square test for statistical heterogeneity was done for each of the comparisons to assess whether differences in treatment effect over individual trials were consistent with natural variation around a constant effect (<a href="./references#CD003074-bbs2-0051" title="CollinsR , GrayR , GodwinJ , PetoR . Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Statistics in Medicine1987;6(3):245‐54. ">Collins 1987</a>). Finally, the ORs were combined across studies giving weight to the number of events in each of the two treatment groups in each separate study using the Mantel‐Haenszel procedure (<a href="./references#CD003074-bbs2-0062" title="MantelN , HaenszelW . Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute1959;22(4):719‐48. ">Mantel 1959</a>). </p> <p>When unfractionated heparin (UFH) is used against placebo, the risk of recurrent VTE is reduced from 20 to 6.7 percent (relative risk reduction (RRR) 67%) (<a href="./references#CD003074-bbs2-0049" title="BrandjesDPM , HeijboerH , BüllerHR , DeRijkM , JagtH , tenCateJW . Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal‐vein thrombosis. New England Journal of Medicine1992;327(21):1485‐9. ">Brandjes 1992</a>). The use of LMWH (mostly twice daily) at least maintains this benefit (upper limit of 95% CI of the OR of LMWH versus UFH = 1.01) (<a href="./references#CD003074-bbs2-0066" title="van denBeltAGM , PrinsMH , LensingAW , CastroAA , ClarkOA , AtallahAN , et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews1999, Issue 4. [DOI: 10.1002/14651858.CD001100] ">van den Belt 1999</a>). Consequently, taking into account the changes of the comparator drug, LMWH twice daily, (OR below one means that once daily LMWH is better), the upper limit of the 95% CI of the primary analysis should not exceed one by more than 0.5, to show that at least 75% of the effect of LMWH twice daily is maintained. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003074-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003074-sec-0051"></div> <section id="CD003074-sec-0052"> <h3 class="title">Description of studies</h3> <section id="CD003074-sec-0053"> <h4 class="title">Results of the search</h4> <p>For this update 18 additional citations relating to 11 studies were retrieved from the search of the Specialised Register. No additional studies were found from the CENTRAL search which were not in the Specialised Register. Five citations were considered to be not relevant for this review from reading the titles and abstracts and a further six studies (12 citations) (<a href="./references#CD003074-bbs2-0012" title="BellostaR , FerrariP , LuzzaniL , CarugatiC , CossuL , TalaricoM , et al. Home therapy with LMWH in deep vein thrombosis: Randomized study comparing single and double daily administrations. Angiology2007;58(3):316‐22. ">Bellosta 2007</a>; <a href="./references#CD003074-bbs2-0018" title="BullerH , DavidsonB , DecoususH , GallusA , GentM , PiovellaF . Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. A randomized trial. Revue de Medecine Interne2005;26(1):82‐3. BullerHR , DavidsonBL , DecoususH , GallusA , GentM , PiovellaF , et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Annals of Internal Medicine2004;140(11):867‐73. BullerHR , The Matisse Investigators. Initial outpatient treatment of venous thromboembolism with fondaparinux (Arixtra(R)): The Matisse trials. Blood2004;104(11):Abstract 705. The Matisse Investigators. The MATISSE‐DVT trial, a randomized, double‐blind study comparing once‐daily fondaparinux (ATRIXA) with the low‐molecular‐weight heparin (LMWH) enoxaparin, twice daily, in the initial treatment of symptomatic deep‐vein thrombosis (DVT). Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Supplement 1:Abstract OC332. ">Buller 2004</a>; <a href="./references#CD003074-bbs2-0019" title="CosmiB , FilippiniM , TontiD , AvruscioG , GhirarduzziA , BucheriniE , et al. STEFLUX Investigators. A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Journal of Thrombosis and Haemostasis2012;10(6):1026‐35. ">Cosmi 2012</a>; <a href="./references#CD003074-bbs2-0030" title="LeizoroviczA . IRIS an ongoing, international, multicentre, open, centrally randomised, parallel group study with tinzaparin or unfractionated heparin (ufh) administered subcutaneously (sc) to patients with deep vein thrombosis (DVT) or pulmonary embolism (PE). XXIst Congress of the International Society on Thrombosis and Haemostasis; 2007 Jul 6‐12; Geneva2007:Abstract no: P‐M‐673. LeizoroviczA . Tinzaparin compared to unfractionated heparin for initial treatment of deep vein thrombosis in very elderly patients with renal insufficiency‐the IRIS Trial. Blood2008; Vol. 112. LeizoroviczA . Tinzaparin compared to unfractionated heparin for initial treatment of deep vein thrombosis in very elderly patients with renal insufficiency‐the IRIS Trial [Abstract No. 434]. ASH2009; Vol. 112, issue 11:166. LeizoroviczA , SiguretV , MottierD . Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The Innohep((R)) in Renal Insufficiency Study (IRIS). Thrombosis Research2011;128(1):27‐34. ">Leizorovicz 2011</a>; <a href="./references#CD003074-bbs2-0036" title="NarinC , ReyhanogluH , TulekB , OnogluR , EgeE , SarigulA , et al. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy. Advances in Therapy2008;25(6):585‐94. ">Narin 2008</a>; <a href="./references#CD003074-bbs2-0041" title="SchellongSM , HaasS , GreinacherA , SchwanebeckU , SiederC , AbletshauserC , et al. An open‐label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN. Expert Opinion on Pharmacotherapy2010;11(18):2953‐61. ">Schellong 2010</a>) were excluded. One citation (<a href="./references#CD003074-bbs2-0059" title="HolmströmM , TornebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1990</a>) was an additional publication of the included study <a href="./references#CD003074-bbs2-0002" title="HolmströmM , BerglundMC , GranqvistS , BrattG , TörnebohmE , LocknerD . Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thrombosis Research1992;67(1):49‐55. HolmströmM , TrönebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1992</a>. </p> </section> <section id="CD003074-sec-0054"> <h4 class="title">Included studies</h4> <p>The five included studies (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>; <a href="./references#CD003074-bbs2-0002" title="HolmströmM , BerglundMC , GranqvistS , BrattG , TörnebohmE , LocknerD . Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thrombosis Research1992;67(1):49‐55. HolmströmM , TrönebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1992</a>; <a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>; <a href="./references#CD003074-bbs2-0004" title="PartschH , KechavarzB , MostbeckA , KöhnH , LippC . Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once‐ or twice‐daily low‐molecular‐weight heparin. Journal of Vascular Surgery1996;24(5):774‐82. ">Partsch 1996</a>; <a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>) incorporated a total of 1508 participants. </p> <p>One of the five included studies included people with PE and DVT (<a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>). The other four studies included only people with DVT. The five included studies used four brands of low molecular weight heparin (LMWH) (enoxaparin, tinzaparin, dalteparin and nadroparin). The manufacturer recommends twice daily administration for nadroparin and enoxaparin. Once daily administration is recommended for tinzaparin and dalteparin. In all the included studies the same generic compounds were used in the head‐to‐head comparison of a once and a twice daily regimen. No authors were contacted for additional information. </p> </section> <section id="CD003074-sec-0055"> <h4 class="title">Excluded studies</h4> <p>See (<a href="./references#CD003074-sec-0091" title="">Characteristics of excluded studies</a>). </p> <p>For this update there were an additional six studies (12 citations) (<a href="./references#CD003074-bbs2-0012" title="BellostaR , FerrariP , LuzzaniL , CarugatiC , CossuL , TalaricoM , et al. Home therapy with LMWH in deep vein thrombosis: Randomized study comparing single and double daily administrations. Angiology2007;58(3):316‐22. ">Bellosta 2007</a>; <a href="./references#CD003074-bbs2-0018" title="BullerH , DavidsonB , DecoususH , GallusA , GentM , PiovellaF . Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. A randomized trial. Revue de Medecine Interne2005;26(1):82‐3. BullerHR , DavidsonBL , DecoususH , GallusA , GentM , PiovellaF , et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Annals of Internal Medicine2004;140(11):867‐73. BullerHR , The Matisse Investigators. Initial outpatient treatment of venous thromboembolism with fondaparinux (Arixtra(R)): The Matisse trials. Blood2004;104(11):Abstract 705. The Matisse Investigators. The MATISSE‐DVT trial, a randomized, double‐blind study comparing once‐daily fondaparinux (ATRIXA) with the low‐molecular‐weight heparin (LMWH) enoxaparin, twice daily, in the initial treatment of symptomatic deep‐vein thrombosis (DVT). Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Supplement 1:Abstract OC332. ">Buller 2004</a>; <a href="./references#CD003074-bbs2-0019" title="CosmiB , FilippiniM , TontiD , AvruscioG , GhirarduzziA , BucheriniE , et al. STEFLUX Investigators. A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Journal of Thrombosis and Haemostasis2012;10(6):1026‐35. ">Cosmi 2012</a>; <a href="./references#CD003074-bbs2-0030" title="LeizoroviczA . IRIS an ongoing, international, multicentre, open, centrally randomised, parallel group study with tinzaparin or unfractionated heparin (ufh) administered subcutaneously (sc) to patients with deep vein thrombosis (DVT) or pulmonary embolism (PE). XXIst Congress of the International Society on Thrombosis and Haemostasis; 2007 Jul 6‐12; Geneva2007:Abstract no: P‐M‐673. LeizoroviczA . Tinzaparin compared to unfractionated heparin for initial treatment of deep vein thrombosis in very elderly patients with renal insufficiency‐the IRIS Trial. Blood2008; Vol. 112. LeizoroviczA . Tinzaparin compared to unfractionated heparin for initial treatment of deep vein thrombosis in very elderly patients with renal insufficiency‐the IRIS Trial [Abstract No. 434]. ASH2009; Vol. 112, issue 11:166. LeizoroviczA , SiguretV , MottierD . Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The Innohep((R)) in Renal Insufficiency Study (IRIS). Thrombosis Research2011;128(1):27‐34. ">Leizorovicz 2011</a>; <a href="./references#CD003074-bbs2-0036" title="NarinC , ReyhanogluH , TulekB , OnogluR , EgeE , SarigulA , et al. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy. Advances in Therapy2008;25(6):585‐94. ">Narin 2008</a>; <a href="./references#CD003074-bbs2-0041" title="SchellongSM , HaasS , GreinacherA , SchwanebeckU , SiederC , AbletshauserC , et al. An open‐label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN. Expert Opinion on Pharmacotherapy2010;11(18):2953‐61. ">Schellong 2010</a>) excluded making a total of 41 excluded studies. </p> <p>Twenty‐six trials did not compare once against twice daily administration of LMWH (<a href="./references#CD003074-bbs2-0007" title="Alhenc‐GelasM , Jestin‐Le GuernicC , VitouxJF , KherA , AiachM , FiessingerJN . Adjusted versus fixed doses of the low‐molecular‐weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin‐Study Group. Thrombosis and Haemostasis1994;71(6):698‐702. ">Alhenc‐Gelas 1994</a>; <a href="./references#CD003074-bbs2-0008" title="AndersenBS . Postoperative activation of the haemostatic system‐‐influence of prolonged thromboprophylaxis in patients undergoing total hip arthroplasty. Haemostasis1997;27(5):219‐27. ">Andersen 1997</a>; <a href="./references#CD003074-bbs2-0009" title="BaraL , LeizoroviczA , PicoletH , SamamaM . Correlation between anti‐Xa and occurrence of thrombosis and haemorrhage in post‐surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post‐surgery Logiparin Study Group. Thrombosis Research1992;65(4‐5):641‐50. ">Bara 1992</a>; <a href="./references#CD003074-bbs2-0010" title="BeckmanJA , DunnK , SasaharaAA , GoldhaberSZ . Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism. Thrombosis and Haemostasis2003;89(6):953‐8. ">Beckman 2003</a>; <a href="./references#CD003074-bbs2-0011" title="BelcaroG , NicolaidesAN , CesaroneMR , LauroraG , DeSanctisMT , IncandelaL , et al. Comparison of low‐molecular‐weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep‐vein thrombosis. Angiology1999;50(10):781‐7. ">Belcaro 1999</a>; <a href="./references#CD003074-bbs2-0014" title="BrattGA , TörnebohmE , JohansonM , AbergW , GranqvistS , LocknerD . Clinical experiences in the administration of a low molecular weight heparin (Fragmin, Kabi‐Vitrum) to healthy volunteers and in the treatment of established deep venous thrombosis. Acta Chirurgica Scandinavica1988;154(Supplement 543):96‐100. ">Bratt 1988</a>; <a href="./references#CD003074-bbs2-0018" title="BullerH , DavidsonB , DecoususH , GallusA , GentM , PiovellaF . Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis. A randomized trial. Revue de Medecine Interne2005;26(1):82‐3. BullerHR , DavidsonBL , DecoususH , GallusA , GentM , PiovellaF , et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Annals of Internal Medicine2004;140(11):867‐73. BullerHR , The Matisse Investigators. Initial outpatient treatment of venous thromboembolism with fondaparinux (Arixtra(R)): The Matisse trials. Blood2004;104(11):Abstract 705. The Matisse Investigators. The MATISSE‐DVT trial, a randomized, double‐blind study comparing once‐daily fondaparinux (ATRIXA) with the low‐molecular‐weight heparin (LMWH) enoxaparin, twice daily, in the initial treatment of symptomatic deep‐vein thrombosis (DVT). Journal of Thrombosis and Haemostasis2003; Vol. 1, issue Supplement 1:Abstract OC332. ">Buller 2004</a>; <a href="./references#CD003074-bbs2-0022" title="FiessingerJN , Lopez‐FernandezM , GattererE , GranqvistS , KherA , OlssonCG , et al. Once‐daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis. Thrombosis and Haemostasis1996;76(2):195‐9. ">Fiessinger 1996</a>; <a href="./references#CD003074-bbs2-0023" title="HarenbergJ , HuckK , BratschH , StehleG , DempfleCE , MallK , et al. Therapeutic application of subcutaneous low‐molecular‐weight heparin in acute venous thrombosis. Haemostasis1990;20(Supplement 1):205‐19. ">Harenberg 1990</a>; <a href="./references#CD003074-bbs2-0024" title="HarenbergJ , StehleG , BlauthM , HuckK , MallK , HeeneDL . Dosage, anticoagulant, and antithrombotic effects of heparin and low‐molecular‐weight heparin in the treatment of deep vein thrombosis. Seminars in Thrombosis and Hemostasis1997;23(1):83‐90. ">Harenberg 1997</a>; <a href="./references#CD003074-bbs2-0025" title="HolmströmM , LindmarkerP , GranqvistS , JohnssonH , LocknerD . A 6‐month venographic follow‐up in 164 patients with acute deep vein thrombosis. Thrombosis and Haemostasis1997;78(2):803‐7. ">Holmström 1997</a>; <a href="./references#CD003074-bbs2-0026" title="HullRD , RaskobGE , BrantRF , PineoGF , ValentineKA . The importance of initial heparin treatment on long‐term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. Archives of Internal Medicine1997;157(20):2317‐21. ">Hull 1997</a>; <a href="./references#CD003074-bbs2-0027" title="HullRD , PineoGF , FrancisC , BergqvistD , FelleniusC , SoderbergK , et al. For the North American Fragmin Trial Investigators. Low‐molecular‐weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double‐blind, randomized comparison. Archives of Internal Medicine2000;160(14):2199‐207. ">Hull 2000a</a>; <a href="./references#CD003074-bbs2-0028" title="HullRD , RaskobGE , BrantRF , PineoGF , ElliottG , SteinPD , et al. For the American‐Canadian Thrombosis Study Group. Low‐molecular‐weight heparin vs heparin in the treatment of patients with pulmonary embolism. Archives of Internal Medicine2000;160(2):229‐36. ">Hull 2000b</a>; <a href="./references#CD003074-bbs2-0031" title="LeroyerC , BressolletteL , OgerE , MansouratiJ , Cheze‐Le RestC , NonentM , et al. For the ANTENOX Study Group. Early versus delayed introduction of oral vitamin K antagonists in combination with low‐molecular‐weight heparin in the treatment of deep vein thrombosis. A randomized clinical trial. Haemostasis1998;28(2):70‐7. ">Leroyer 1998</a>; <a href="./references#CD003074-bbs2-0032" title="LindmarkerP , HolmströmM , GranqvistS , JohnssonH , LocknerD . Comparison of once‐daily subcutaneous Fragmin(TM) with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thrombosis and Haemostasis1994;72(2):186‐90. ">Lindmarker 1994</a>; <a href="./references#CD003074-bbs2-0033" title="LuomanmakiK , GrankvistS , HallertC , JauroI , KetolaK , KimHC , et al. A multicentre comparison of once‐daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis. Journal of Internal Medicine1996;240(2):85‐92. ">Luomanmaki 1996</a>; <a href="./references#CD003074-bbs2-0034" title="MeyerG , BrenotF , PacouretG , SimonneauG , Gillet JuvinK , CharbonnierB , et al. Subcutaneous low‐molecular‐weight heparin Fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study. Thrombosis and Haemostasis1995;74(6):1432‐5. ">Meyer 1995</a>; <a href="./references#CD003074-bbs2-0037" title="OffordR , LloydAC , AndersonP , BearneA . Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients. Pharmacy World and Science2004;26(4):214‐20. ">Offord 2004</a>; <a href="./references#CD003074-bbs2-0039" title="PiniM , AielloS , ManottiC , PattaciniC , QuintavallaR , PoliT , et al. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thrombosis and Haemostasis1994;72(2):191‐7. ">Pini 1994</a>; <a href="./references#CD003074-bbs2-0040" title="SandsetPM , DahlT , StirisM , RostadB , ScheelB , AbildgaardU . A double‐blind and randomized placebo‐controlled trial of low molecular weight heparin once daily to prevent deep‐vein thrombosis in acute ischemic stroke. Seminars in Thrombosis and Hemostasis1990;16(Supplement):25‐33. ">Sandset 1990</a>; <a href="./references#CD003074-bbs2-0041" title="SchellongSM , HaasS , GreinacherA , SchwanebeckU , SiederC , AbletshauserC , et al. An open‐label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN. Expert Opinion on Pharmacotherapy2010;11(18):2953‐61. ">Schellong 2010</a>; <a href="./references#CD003074-bbs2-0042" title="SimonneauG , CharbonnierB , DecoususH , PlanchonB , NinetJ , SieP , et al. Subcutaneous low‐molecular‐weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Archives of Internal Medicine1993;153(13):1541‐6. ">Simonneau 1993</a>; <a href="./references#CD003074-bbs2-0043" title="SimonneauG , SorsH , CharbonnierB , PageY , LaabanJ‐P , AzarianR , et al. For the THESEE Study Group. A comparison of low‐molecular‐weight heparin with unfractionated heparin for acute pulmonary embolism. New England Journal of Medicine1997;337(10):663‐9. ">Simonneau 1997</a>; <a href="./references#CD003074-bbs2-0044" title="StrickerH , MarchettiO , HaeberliA , MombelliG . Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis. Thrombosis and Haemostasis1999;82(4):1227‐31. ">Stricker 1999</a>; <a href="./references#CD003074-bbs2-0046" title="WartskiM , CollignonMA . Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou Heparin Standard: Evaluation dans l'Embolie Pulmonaire Study. Journal of Nuclear Medicine2000;41(6):1043‐8. ">Wartski 2000</a>). Nine did not feature VTE as the initial event (<a href="./references#CD003074-bbs2-0006" title="AgnelliG , IorioA , RengaC , BoschettiE , NenciGG , OfosuFA , et al. Prolonged antithrombin activity of low‐molecular‐weight heparins: Clinical implications for the treatment of thromboembolic diseases. Circulation1995;92(10):2819‐24. ">Agnelli 1995</a>; <a href="./references#CD003074-bbs2-0013" title="BoneuB , NavarroC , CambusJP , CaplainH , d'AzemarP , NecciariJ , et al. Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU x ml(‐1)) delivered for 10 days at therapeutic dose. Thrombosis and Haemostasis1998;79(2):338‐41. ">Boneu 1998</a>; <a href="./references#CD003074-bbs2-0015" title="BrattG , AbergW , JohanssonM , TörnebohmE , GranqvistS , LocknerD . Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT). Thrombosis and Haemostasis1990;64(4):506‐10. ">Bratt 1990</a>; <a href="./references#CD003074-bbs2-0019" title="CosmiB , FilippiniM , TontiD , AvruscioG , GhirarduzziA , BucheriniE , et al. STEFLUX Investigators. A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Journal of Thrombosis and Haemostasis2012;10(6):1026‐35. ">Cosmi 2012</a>; <a href="./references#CD003074-bbs2-0020" title="ErikssonBI , BergqvistD , KaleboP , DahlOE , LindbrattS , BylockA , et al. Melagatran for thrombin inhibition in orthopaedic surgery. Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial. Lancet2002;360(9344):1441‐7. ">Erikson 2002</a>; <a href="./references#CD003074-bbs2-0021" title="ErikssonBI , AgnelliG , CohenAT , DahlOE , MouretP , RosencherN , et al. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. Thrombosis and Haemostasis2003;89(2):288‐96. ">Erikson 2003</a>; <a href="./references#CD003074-bbs2-0035" title="MismettiP , ReynaudJ , Tardy‐PonceB , Laporte‐SimitsidisS , ScullyM , GoodwynC , et al. Chrono‐pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteers. Thrombosis and Haemostasis1995;74(2):660‐6. ">Mismetti 1995</a>; <a href="./references#CD003074-bbs2-0038" title="PettilaV , LeinonenP , MarkkolaA , HiilesmaaV , KaajaR . Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thrombosis and Haemostasis2002;87(2):182‐6. ">Petilla 2002</a>; <a href="./references#CD003074-bbs2-0045" title="TurpieAG , BauerKA , ErikssonBI , LassenMR , PENTATHALON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip‐replacement surgery: a randomised double‐blind trial. Lancet2002;359(9319):1721‐6. ">Turpie 2002</a>). One study involved the use of unfractionated heparin for the first five days (<a href="./references#CD003074-bbs2-0030" title="LeizoroviczA . IRIS an ongoing, international, multicentre, open, centrally randomised, parallel group study with tinzaparin or unfractionated heparin (ufh) administered subcutaneously (sc) to patients with deep vein thrombosis (DVT) or pulmonary embolism (PE). XXIst Congress of the International Society on Thrombosis and Haemostasis; 2007 Jul 6‐12; Geneva2007:Abstract no: P‐M‐673. LeizoroviczA . Tinzaparin compared to unfractionated heparin for initial treatment of deep vein thrombosis in very elderly patients with renal insufficiency‐the IRIS Trial. Blood2008; Vol. 112. LeizoroviczA . Tinzaparin compared to unfractionated heparin for initial treatment of deep vein thrombosis in very elderly patients with renal insufficiency‐the IRIS Trial [Abstract No. 434]. ASH2009; Vol. 112, issue 11:166. LeizoroviczA , SiguretV , MottierD . Safety profile of tinzaparin versus subcutaneous unfractionated heparin in elderly patients with impaired renal function treated for acute deep vein thrombosis: The Innohep((R)) in Renal Insufficiency Study (IRIS). Thrombosis Research2011;128(1):27‐34. ">Leizorovicz 2011</a>). In three studies (<a href="./references#CD003074-bbs2-0016" title="BreddinHK , Hach‐WunderleV , NakovR , Kakkar VV. For the CORTES Investigators. Effects of a low‐molecular‐weight heparin on thrombus regression and recurrent thromboembolism in patients with deep‐vein thrombosis. New England Journal of Medicine2001;344(9):626‐31. ">Breddin 2001</a>; <a href="./references#CD003074-bbs2-0017" title="BreddinHK , KadziolaZ , ScullyM , NakovR , MisselwitzF , KakkarVV . Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis. Thrombosis and Haemostasis2003;89(2):272‐9. ">Breddin 2003</a>; <a href="./references#CD003074-bbs2-0029" title="KakkarVV , HoppensteadDA , FareedJ , KadziolaZ , ScullyM , NakovR , et al. Randomized trial of different regimens of heparins and in vivo thrombin generation in acute deep vein thrombosis. Blood2002;99(6):1965‐70. ">Kakkar 2002</a>), there were differences in concomitant medication whereby vitamin K antagonists were administered to participants in only one treatment group or treatment with vitamin K antagonists was started a few weeks later in one treatment group compared with the other group. One other study was excluded because it used different LMWH, with once daily versus twice daily for one month only and following that, the twice daily treatment arm reverted to once daily prophylactic dose. This makes comparing once daily versus twice daily regimens untenable as there were no results for effectiveness of the regimens at one month (<a href="./references#CD003074-bbs2-0012" title="BellostaR , FerrariP , LuzzaniL , CarugatiC , CossuL , TalaricoM , et al. Home therapy with LMWH in deep vein thrombosis: Randomized study comparing single and double daily administrations. Angiology2007;58(3):316‐22. ">Bellosta 2007</a>). One trial was excluded as it was a retrospective study (<a href="./references#CD003074-bbs2-0036" title="NarinC , ReyhanogluH , TulekB , OnogluR , EgeE , SarigulA , et al. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy. Advances in Therapy2008;25(6):585‐94. ">Narin 2008</a>). </p> </section> </section> <section id="CD003074-sec-0056"> <h3 class="title">Risk of bias in included studies</h3> <p>All five included studies were randomised clinical trials. Two studies had a double‐blind design (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>; <a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>). Two other studies were single blind (<a href="./references#CD003074-bbs2-0002" title="HolmströmM , BerglundMC , GranqvistS , BrattG , TörnebohmE , LocknerD . Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thrombosis Research1992;67(1):49‐55. HolmströmM , TrönebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1992</a>; <a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>). One study did not mention blinding (<a href="./references#CD003074-bbs2-0004" title="PartschH , KechavarzB , MostbeckA , KöhnH , LippC . Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once‐ or twice‐daily low‐molecular‐weight heparin. Journal of Vascular Surgery1996;24(5):774‐82. ">Partsch 1996</a>). There were no indications from any of the studies that data were not analysed on an intention‐to‐treat basis. Participants were lost to follow up in only two studies. In one study, one person (0.3%) was lost to follow up in the twice daily group (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>). In the other study (<a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>), seven participants (2.3%) from the group treated once daily were lost to follow up, and seven participants (2.2%) from the group treated twice daily were lost to follow up. There were no disagreements between the two review authors regarding the issue of internal validity. </p> </section> <section id="CD003074-sec-0057"> <h3 class="title" id="CD003074-sec-0057">Effects of interventions</h3> <section id="CD003074-sec-0058"> <h4 class="title">Incidence of recurrent venous thromboembolism (VTE)</h4> <p>Three of the five included studies reported on the recurrence of symptomatic VTE (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>; <a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>; <a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>). In the smallest of these (<a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>), no recurrent events were reported in either treatment group, hence an OR could not be calculated. In another study (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>), a statistically non‐significant lower incidence of recurrent VTE was shown in participants receiving LMWH once daily compared with those who received LMWH twice daily. While in the third study a lower incidence of VTE could be observed, which was also not statistically significant, in participants treated with LMWH twice daily (<a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>). When the results of these two studies (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>; <a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>) were combined, 26 (4.2%) of the 624 participants treated with LMWH once daily and 33 (5.0%) of the 657 participants treated with LMWH twice daily had a recurrent thromboembolic event. Analysis of the pooled data showed no statistically significant difference in the incidence of recurrent thromboembolic events between LMWH once daily compared with LMWH twice daily (OR 0.82, 0.49 to 1.39; <a href="./references#CD003074-fig-0001" title="">Analysis 1.1</a>). Thus, the a priori determined criterion for equivalence was satisfied. The test for statistical heterogeneity was negative (P = 0.07), although borderline. Visual inspection does not give the impression of heterogeneity. </p> </section> <section id="CD003074-sec-0059"> <h4 class="title">Incidence of haemorrhagic events</h4> <p>All the included studies reported on the occurrence of major haemorrhagic events. In one study none of the participants had a haemorrhagic event so an OR could not be calculated (<a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>). Two studies showed a statistically non‐significant lower incidence of haemorrhagic events in people treated with LMWH once daily (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>; <a href="./references#CD003074-bbs2-0002" title="HolmströmM , BerglundMC , GranqvistS , BrattG , TörnebohmE , LocknerD . Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thrombosis Research1992;67(1):49‐55. HolmströmM , TrönebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1992</a>). The other two studies showed a non‐significant lower risk of major haemorrhage in people treated with LMWH twice daily compared with people treated once daily (<a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>; <a href="./references#CD003074-bbs2-0004" title="PartschH , KechavarzB , MostbeckA , KöhnH , LippC . Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once‐ or twice‐daily low‐molecular‐weight heparin. Journal of Vascular Surgery1996;24(5):774‐82. ">Partsch 1996</a>). When data were combined it could be seen that 16 (2.2%) out of a total 742 participants in the once daily treatment groups suffered a haemorrhagic event compared with 22 (2.9%) events in the 766 participants in the twice daily treatment groups. Pooled analysis of the study results showed a non‐significant lower incidence in haemorrhagic events in people treated with LMWH once daily compared with those who had a regimen of twice daily administration (OR 0.77, 0.40 to 1.45; <a href="./references#CD003074-fig-0002" title="">Analysis 1.2</a>). The statistical test for heterogeneity was negative (P = 0.63). </p> </section> <section id="CD003074-sec-0060"> <h4 class="title">Extension of thrombus size</h4> <p>Data on change in thrombus size could be extracted from two studies (<a href="./references#CD003074-bbs2-0002" title="HolmströmM , BerglundMC , GranqvistS , BrattG , TörnebohmE , LocknerD . Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thrombosis Research1992;67(1):49‐55. HolmströmM , TrönebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1992</a>; <a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>). In the larger of these (<a href="./references#CD003074-bbs2-0002" title="HolmströmM , BerglundMC , GranqvistS , BrattG , TörnebohmE , LocknerD . Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thrombosis Research1992;67(1):49‐55. HolmströmM , TrönebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1992</a>), interpretable repeat phlebography was available for only 87 of 101 participants. The number of people in whom an improvement of the thrombus size was found was not statistically significant. The thrombus size improved in 23 (54.8%) of the 42 participants treated with LMWH once daily and 23 (51.1%) of the 45 treated twice daily (OR 1.16, 0.50 to 2.69). The other study (<a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>) reported that in the once daily group the thrombus size improved in six out of 10 participants; in the twice daily group the thrombus size improved in three out of 10 participants (OR 3.50, 0.55 to 22.30). Therefore, a combined OR could be calculated which showed no statistically significant difference between the treatment groups (OR 1.41, 0.66 to 3.01; <a href="./references#CD003074-fig-0003" title="">Analysis 1.3</a>). The test for heterogeneity was negative (P = 0.29). </p> </section> <section id="CD003074-sec-0061"> <h4 class="title">Mortality</h4> <p>Four studies reported data on overall mortality (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>; <a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>; <a href="./references#CD003074-bbs2-0004" title="PartschH , KechavarzB , MostbeckA , KöhnH , LippC . Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once‐ or twice‐daily low‐molecular‐weight heparin. Journal of Vascular Surgery1996;24(5):774‐82. ">Partsch 1996</a>; <a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>). In the smallest study (<a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>), the mortality in both treatment groups was zero. In another study (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>), there were fewer deaths amongst the people treated with LMWH once daily, however, this difference was not statistically significant. In the two other studies (<a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>; <a href="./references#CD003074-bbs2-0004" title="PartschH , KechavarzB , MostbeckA , KöhnH , LippC . Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once‐ or twice‐daily low‐molecular‐weight heparin. Journal of Vascular Surgery1996;24(5):774‐82. ">Partsch 1996</a>), a statistically non‐significant lower number of deaths was observed in people who received LMWH twice daily compared with people who received LMWH once daily. Combining these results showed that 23 (3.3%) out of a total of 700 in the once daily groups and 21 (2.9%) out of a total of 721 in the twice daily groups died. A pooled analysis of the data showed that there was no statistically significant difference in mortality between people who are treated with LMWH twice daily compared with people treated with LMWH once daily (OR 1.14, 0.62 to 2.08; <a href="./references#CD003074-fig-0004" title="">Analysis 1.4</a>). The test for statistical heterogeneity on mortality was negative (P = 0.34). </p> </section> <section id="CD003074-sec-0062"> <h4 class="title">Post‐thrombotic syndrome</h4> <p>None of the five included studies reported data on post‐thrombotic syndrome.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003074-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003074-sec-0063"></div> <p>In this systematic review we assessed the relative efficacy and safety of once daily administration of low molecular weight heparin (LMWH) compared with a twice daily treatment regimen. Five studies comprising a total of 1508 participants were included. Procedures of randomisation and blinded outcome assessment assured reliable estimates of the pooled ORs (<a href="./references#CD003074-bbs2-0065" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association1995;273(5):408‐12. ">Schulz 1995</a>). We found no statistically significant difference in efficacy with respect to recurrent thromboembolic events between the once daily and twice daily treatment regimens. The predefined criterion for equivalence was met since the confidence interval of the pooled OR for recurrence of VTE did not exceed 1.5. In fact, the upper limit of the 95% confidence interval was 1.39, which indicates that at least approximately 80% of the efficacy of the twice daily regimen was maintained by the once daily regimen. The observed clinical equivalence with regard to efficacy was accompanied by similar rates of bleeding complications with both the once and twice daily regimens. Also, mortality rates were low and similar in both groups. No data were available for the incidence of the development of post‐thrombotic syndrome. </p> <p>With regard to our two main outcome events, recurrent VTE and major haemorrhage, the following should be stated: although the pooled OR (OR 0.82, 0.49 to 1.39) for recurrent thromboembolic events was based on only two studies, it is likely that it is a reliable estimate since the methodological quality of these two largest studies (including 1261 of the total of 1508 participants) was high. Moreover, the two studies that evaluated the change in thrombus size confirm the absence of an important difference in efficacy (<a href="./references#CD003074-bbs2-0002" title="HolmströmM , BerglundMC , GranqvistS , BrattG , TörnebohmE , LocknerD . Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thrombosis Research1992;67(1):49‐55. HolmströmM , TrönebohmE , BerglundMC , GranqvistS , LocknerD . Fragmin (KABI) subcutaneously once or twice daily in the treatment of deep venous thrombosis (DVT). Journal of Internal Medicine Supplement1990;733:31. ">Holmström 1992</a>; <a href="./references#CD003074-bbs2-0005" title="SiegbahnA , Y‐HassanS , BobergJ , BylundH , NeerstrandHS , ØstergaardP , et al. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH‐Novo. Thrombosis Research1989;55(6):767‐78. ">Siegbahn 1989</a>). In Holmström's study, a relatively large number of the repeat venographs (14 out of 101) were not available. However, the numbers between the two groups (six in the twice daily and eight in the once daily) were comparable. Therefore, it is unlikely that the lack of available venographs in the analysis has biased the results. Data on the other main outcome, risk for major haemorrhagic events, could be derived from all studies. The observed OR indicates at least equal safety for the once daily regimen. </p> <p>In meta‐analyses of studies comparing UFH with LMWH in relation to recurrent VTE and bleeding outcomes, it appeared that LMWH is at least as effective and safe as UFH (<a href="./references#CD003074-bbs2-0052" title="DolovichLR , GinsbergJS , DouketisJD , HolbrookAM , CheahG . A meta‐analysis comparing low‐molecular‐weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Archives of Internal Medicine2000;160(2):181‐8. ">Dolovich 2000</a>; <a href="./references#CD003074-bbs2-0053" title="ErkensPMG , PrinsMH . Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD001100.pub3] ">Erkens 2010</a>; <a href="./references#CD003074-bbs2-0054" title="GouldMK , DembitzerAD , DoyleRL , HastieTJ , GarberAM . Low‐molecular‐weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta‐analysis of randomized, controlled trials. Annals of Internal Medicine1999;130(10):800‐9. ">Gould 1999</a>). In addition, in all three studies it was concluded that LMWH shows a statistically significant decrease in overall mortality compared with UFH. Frequency of administration was beyond the main scope of these studies. In only one of these meta‐analyses a comparison was made between once daily and twice daily administration of LMWH and it was concluded that once daily administration of LMWH is as effective and safe as a twice daily treatment regimen (<a href="./references#CD003074-bbs2-0052" title="DolovichLR , GinsbergJS , DouketisJD , HolbrookAM , CheahG . A meta‐analysis comparing low‐molecular‐weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Archives of Internal Medicine2000;160(2):181‐8. ">Dolovich 2000</a>). This comparison was made across studies, rather than based on direct randomised comparisons. Therefore, the conclusion drawn by the authors can be potentially biased by group differences. However, the results are in agreement with our findings. </p> <p>This systematic review demonstrates equivalence in efficacy and safety, in the short term, between once and twice daily administration of LMWH for VTE. It should be noted that there are no data available on the effect of dosing frequency on long‐term recurrent thromboembolic events and the development of the post‐thrombotic syndrome. Further research will be required to answer these clinically relevant questions definitively. However, an important difference in these outcomes seems implausible based on the short duration of the initial treatment regimens and their fully comparable efficacy at that stage. </p> <p>It is questionable whether the results obtained from the small number of PE patients included in this systematic review can be extrapolated to all people with PE. However, if we consider DVT and PE as different manifestations of the same disease, VTE, we can conclude from the evidence presented in this systematic review, that a once daily treatment regimen is not significantly different ‐ with respect to efficacy and safety ‐ to a twice daily regimen in people treated for an first episode of DVT. Therefore, we have no reason to suppose that the recurrence risk in people with PE is increased. However, further research should be done to give more insight in the impact of different LMWH regimens in people with PE. </p> <p>In the studies of Charbonnier (<a href="./references#CD003074-bbs2-0001" title="CharbonnierBA , FiessingerJN , BangaJD , WenzelE , d'AzemarP , SagnardL . Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thrombosis and Haemostasis1998;79(5):897‐901. ">Charbonnier 1998</a>) and Merli (<a href="./references#CD003074-bbs2-0003" title="MerliG , SpiroTE , OlssonCG , AbildgaardU , DavidsonBL , EldorA , et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine2001;134(3):191‐202. ">Merli 2001</a>), different LMWH compounds were used (nadroparin and enoxaparin, respectively). A meta‐analysis (<a href="./references#CD003074-bbs2-0067" title="van derHeijdenJF , PrinsMH , BüllerHR . For the initial treatment of venous thromboembolism: are all low‐molecular‐weight heparin compounds the same?. Thrombosis Research2000;100(2):V121‐30. ">van der Heijden 2000</a>) concluded that safety and efficacy of LMWH is comparable for different compounds of LMWH used in the initial treatment of VTE. Therefore, we believe that different LMWH compounds do not differ with respect to safety and efficacy in relation to a once or twice daily regimen. The best available evidence is presented in this systematic review but further research should be performed to elucidate whether the safety and efficacy of different LMWH compounds are comparable in a once or twice daily regimen. </p> </section> </section> <div class="figures-list"> <div class="figure" id="CD003074-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/urn:x-wiley:14651858:media:CD003074:CD003074-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_t/tCD003074-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Outcomes, Outcome 1 Recurrent thromboembolic events." data-id="CD003074-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Outcomes, Outcome 1 Recurrent thromboembolic events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references#CD003074-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003074-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/urn:x-wiley:14651858:media:CD003074:CD003074-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_t/tCD003074-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Outcomes, Outcome 2 Haemorraghic events." data-id="CD003074-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Outcomes, Outcome 2 Haemorraghic events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references#CD003074-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003074-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/urn:x-wiley:14651858:media:CD003074:CD003074-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_t/tCD003074-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Outcomes, Outcome 3 Improvement of thrombus size." data-id="CD003074-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Outcomes, Outcome 3 Improvement of thrombus size.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references#CD003074-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003074-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/urn:x-wiley:14651858:media:CD003074:CD003074-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_t/tCD003074-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Outcomes, Outcome 4 Mortality." data-id="CD003074-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Outcomes, Outcome 4 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references#CD003074-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/media/CDSR/CD003074/image_n/nCD003074-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="comparison" data-id="CD003074-tbl-0001"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrent thromboembolic events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Haemorraghic events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.40, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Improvement of thrombus size <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.66, 3.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.62, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003074.pub3/references#CD003074-tbl-0001">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003074.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003074-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003074-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003074-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="pt#CD003074-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD003074-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003074\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003074\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003074\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003074\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003074\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=z6k50IFd&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003074.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003074.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003074.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003074.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003074.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714958083"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003074.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714958087"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003074.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7b5abd189368',t:'MTc0MDcxNDk1OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 